Your session is about to expire
← Back to Search
Behavioural Intervention
CARE for Cancer Caregivers
N/A
Waitlist Available
Led By Areej El-Jawahri, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
A relative or a friend who either lives with the patient or has in-person contact with him or her at least twice per week and is identified as the primary caregiver for transplant
Adult caregivers (≥18 years) of patients undergoing autologous or allogeneic HCT at MGH, and they must attend the HCT consent visit with the patient
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Study Summary
This trial is testing if a psychological intervention can improve quality of life and mood for caregivers of stem cell transplant patients.
Who is the study for?
This trial is for adult caregivers (18+ years) of cancer patients undergoing stem cell transplant. Caregivers must be in close contact with the patient, speak English or use an interpreter, and attend a specific consent visit. Those with uncontrolled psychiatric conditions or diseases that prevent participation are excluded.Check my eligibility
What is being tested?
The study is testing a psychological intervention called CARE against standard care given during stem cell transplants to see if it improves the quality of life and mood of caregivers.See study design
What are the potential side effects?
Since this is a psychological intervention, there may not be physical side effects like with medication. However, participants might experience emotional discomfort or stress when discussing personal topics.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have a primary caregiver who sees me at least twice a week.
Select...
I am an adult caregiver for a patient getting a stem cell transplant and attended the consent visit.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility of the intervention (feasibility description below)
Secondary outcome measures
Compare Caregiver QOL (CarGOQOL) between the study arms
Compare caregiver mood (HADS) between the study arms
Compare caregiver self-efficacy (CASE-t) between the study arms
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CARE interventionExperimental Treatment1 Intervention
Six psychological intervention sessions in-person or via video conferencing conducted by a trained psychologist
The CARE intervention contain 3 component
a psychoeducational component to address preparednessmanage expectations, and develop caregiving skills
a psychosocial component focusing on coping strategies, mindfulness, and facilitating acceptance while living with uncertainty
a self-care component to promote caregiver health and well-being
Group II: Standard transplant careActive Control2 Interventions
Standard Transplant Care
Social work consults to help caregivers only upon request
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,928 Previous Clinical Trials
13,198,255 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,053 Total Patients Enrolled
Areej El-Jawahri, MDPrincipal InvestigatorMassachusetts General Hospital
18 Previous Clinical Trials
4,412 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research project actively seeking participants?
"The available information on clinicaltrials.gov indicates that enlistment for this particular experiment is not currently active, since the last revision was made in August of 2021. However, there are 485 other medical studies actively recruiting participants presently."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger